RAPT Therapeutics Inc (RAPT) — Financial Flexibility Index
RAPT Therapeutics Inc (RAPT) has a Financial Flexibility Index of -0.91x as of September 2025. Free cash flow of $-12.46 Million (operating CF $-12.46 Million minus capex $0.00) represents -1% of total liabilities ($13.76 Million). Check RAPT Therapeutics Inc (RAPT) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
RAPT Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for RAPT Therapeutics Inc across 8 annual periods. See RAPT Therapeutics Inc (RAPT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for RAPT Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for RAPT Therapeutics Inc. For the full company profile including market capitalisation, see RAPT market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.65x | $-83.17 Million | $-83.30 Million | $50.42 Million | ▲ +54.8% |
| 2023 | -3.65x | $-95.92 Million | $-97.05 Million | $26.29 Million | ▼ -9.8% |
| 2022 | -3.32x | $-69.93 Million | $-70.77 Million | $21.04 Million | ▲ +32.4% |
| 2021 | -4.92x | $-60.27 Million | $-61.03 Million | $12.26 Million | ▼ -81.4% |
| 2020 | -2.71x | $-40.09 Million | $-40.49 Million | $14.79 Million | ▲ +10.0% |
| 2019 | -3.01x | $-34.59 Million | $-35.47 Million | $11.48 Million | ▲ +42.6% |
| 2018 | -5.25x | $-29.45 Million | $-32.95 Million | $5.61 Million | ▼ -2176.9% |
| 2017 | -0.23x | $-26.00 Million | $-27.12 Million | $112.80 Million | — |